Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial ...
Tuesday, March 24 is the last day for undergraduate and graduate students (law students excluded) to complete the following actions for a full-semester Main Campus class:* If you've satisfactorily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results